Eclosion SA

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up can reasonably attract risk capital. Eclosion helps you to cross the bridge to convert your innovation into a realistic venture and to enter into its growth phase.

Eclosion SA, established in 2001 and headquartered in Switzerland, Europe., specializes in Seed, Late Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Financial Services, Banking, Venture Capital, Information Technology, Life Science, Medical, Women's. The organization boasts a portfolio of 16 investments, with an average round size of $11.8M and 6 successful exits. Their recent investments include Genkyotex, Andera Partners, MP Healthcare Venture Management, Vesalius Biocapital Partners, Fondation d'Aide aux Entreprises. The highest investment round they participated in was $3.8B. Among their most notable exits are Genkyotex and Andera Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.